According to information from the plaintiff’s law firms, a U.S. jury in Georgia has ordered Bayer to pay approximately $2.1 billion to a plaintiff who alleged that the company’s Roundup weed killer caused his cancer. Bayer stated that it intends to appeal the verdict. This legal settlement is one of the largest in a Roundup-related case and represents another challenge for Bayer, a major player in the seeds and pesticides industry.
Bayer has already paid around $10 billion to resolve disputed claims linking Roundup, containing glyphosate, to cancer. The company has allocated $5.9 billion to address over 60,000 pending cases. The recent Georgia verdict includes $65 million in compensatory damages and $2 billion in punitive damages. Bayer expressed disagreement with the jury’s decision, citing scientific consensus and regulatory assessments globally.
The plaintiff’s law firms, Arnold & Itkin LLP and Kline & Specter PC, confirmed the verdict to Reuters. Bayer believes it has strong grounds for appeal to challenge the decision and potentially reduce the excessive damages awarded. Earlier this month, Bayer reportedly informed U.S. lawmakers that it might discontinue Roundup sales unless legal protections against product liability lawsuits were reinforced.
